Evidence map›Paper›PMID 32817637›Full record

ArticlePloS one2020

ADAMTS12, a new candidate gene for pediatric stroke.

Anika Witten, Frank Rühle, Marlous de Witt, Andrei Barysenka, Michael Stach, Ralf Junker, Ulrike Nowak-Göttl, Monika Stoll

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Global proteomic analysis of extracellular matrix in mouse and human brain highlights relevance to cerebrovascular disease.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Anika WittenInstitute of Human Genetics, Genetic Epidemiology, University of Münster, Münster, Germany.ORCID 0000-0002-8245-7105
Frank RühleInstitute of Human Genetics, Genetic Epidemiology, University of Münster, Münster, Germany.
Marlous de WittInstitute of Human Genetics, Genetic Epidemiology, University of Münster, Münster, Germany.
Andrei BarysenkaInstitute of Human Genetics, Genetic Epidemiology, University of Münster, Münster, Germany.
Michael StachIT Service Centre, University Hospital of Münster, Münster, Germany.
Ralf JunkerInstitute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Germany.
Ulrike Nowak-GöttlInstitute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Germany.
Monika StollInstitute of Human Genetics, Genetic Epidemiology, University of Münster, Münster, Germany.ORCID 0000-0002-2711-4281
University of Münster · DEUniversity Hospital Schleswig-Holstein · DEUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We recently reported a family-based genome wide association study (GWAS) for pediatric stroke pointing our attention to two significantly associated genes of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) gene family ADAMTS2 (rs469568, p = 8x10-6) and ADAMTS12 (rs1364044, p = 2.9x10-6). To further investigate these candidate genes, we applied a targeted resequencing approach on 48 discordant sib-pairs for pediatric stroke followed by genotyping of the detected non-synonymous variants in the full cohort of 270 offspring trios and subsequent fine mapping analysis. We identified eight non-synonymous SNPs in ADAMTS2 and six in ADAMTS12 potentially influencing the respective protein function. These variants were genotyped within a cohort of 270 affected offspring trios, association analysis revealed the ADAMTS12 variant rs77581578 to be significantly under-transmitted (p = 6.26x10-3) to pediatric stroke patients. The finding was validated in a pediatric venous thromboembolism (VTE) cohort of 189 affected trios. Subsequent haplotype analysis of ADAMTS12 detected a significantly associated haplotype comprising the originally identified GWAS variant. Several ADAMTS genes such as ADAMTS13 are involved in thromboembolic disease process. Here, we provide further evidence for ADAMTS12 to likely play a role in pediatric stroke. Further functional studies are warranted to assess the functional role of ADAMTS12 in the pathogenesis of stroke.

Indexed as

Genetic Predisposition to DiseaseADAMTS ProteinsChildFemaleGenome-Wide Association StudyGenotypeHaplotypesHumansMalePediatricsPolymorphism, Single NucleotideStrokeADAMTS12 protein, humanADAMTS2 protein, humanADAMTS Proteins

Identifiers

PMID32817637
PMCPMC7446847
OpenAlexW3080395040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.